Insufficient scRNA-seq data for expression of WNT9B at single-cell level.
Insufficient scRNA-seq data for expression of WNT9B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 84% | 25.47 | 2210 / 2642 | 33% | 0.63 | 236 / 705 |
kidney | 96% | 123.61 | 85 / 89 | 15% | 0.30 | 131 / 901 |
spleen | 97% | 67.85 | 234 / 241 | 0% | 0 | 0 / 0 |
breast | 84% | 35.65 | 384 / 459 | 4% | 0.06 | 42 / 1118 |
heart | 86% | 37.70 | 739 / 861 | 0% | 0 | 0 / 0 |
adipose | 82% | 33.24 | 990 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 77% | 16.87 | 198 / 258 | 5% | 0.07 | 11 / 230 |
lung | 75% | 25.33 | 432 / 578 | 2% | 0.03 | 25 / 1155 |
thymus | 71% | 17.47 | 464 / 653 | 6% | 0.08 | 34 / 605 |
uterus | 72% | 22.85 | 123 / 170 | 3% | 0.13 | 16 / 459 |
skin | 69% | 27.69 | 1244 / 1809 | 1% | 0.01 | 3 / 472 |
prostate | 68% | 17.23 | 166 / 245 | 1% | 0.02 | 4 / 502 |
esophagus | 67% | 15.41 | 972 / 1445 | 1% | 0.01 | 2 / 183 |
blood vessel | 62% | 21.34 | 829 / 1335 | 0% | 0 | 0 / 0 |
bladder | 57% | 13.62 | 12 / 21 | 3% | 0.19 | 13 / 504 |
liver | 44% | 26.78 | 100 / 226 | 3% | 0.13 | 14 / 406 |
intestine | 44% | 6.44 | 429 / 966 | 1% | 0.02 | 4 / 527 |
stomach | 39% | 7.72 | 141 / 359 | 3% | 0.05 | 9 / 286 |
pancreas | 37% | 4.47 | 121 / 328 | 3% | 0.07 | 6 / 178 |
ovary | 25% | 3.77 | 45 / 180 | 0% | 0.04 | 2 / 430 |
muscle | 19% | 2.21 | 154 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.24 | 16 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0009786 | Biological process | regulation of asymmetric cell division |
GO_0001701 | Biological process | in utero embryonic development |
GO_1904948 | Biological process | midbrain dopaminergic neuron differentiation |
GO_0061303 | Biological process | cornea development in camera-type eye |
GO_0061038 | Biological process | uterus morphogenesis |
GO_0003339 | Biological process | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0009267 | Biological process | cellular response to starvation |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0072181 | Biological process | mesonephric duct formation |
GO_0030182 | Biological process | neuron differentiation |
GO_0060021 | Biological process | roof of mouth development |
GO_0072003 | Biological process | kidney rudiment formation |
GO_0045165 | Biological process | cell fate commitment |
GO_0030539 | Biological process | male genitalia development |
GO_0072038 | Biological process | mesenchymal stem cell maintenance involved in nephron morphogenesis |
GO_0035150 | Biological process | regulation of tube size |
GO_0072044 | Biological process | collecting duct development |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0032526 | Biological process | response to retinoic acid |
GO_0072046 | Biological process | establishment of planar polarity involved in nephron morphogenesis |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0072174 | Biological process | metanephric tubule formation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0039706 | Molecular function | co-receptor binding |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0005109 | Molecular function | frizzled binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | WNT9B |
Protein name | Protein Wnt-9b (Protein Wnt-14b) (Protein Wnt-15) Protein Wnt |
Synonyms | WNT15 UNQ6973/PRO21956 WNT14B |
Description | FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Functions in the canonical Wnt/beta-catenin signaling pathway. Required for normal embryonic kidney development, and for normal development of the urogenital tract, including uterus and part of the oviduct and the upper vagina in females, and epididymis and vas deferens in males. Activates a signaling cascade in the metanephric mesenchyme that induces tubulogenesis. Acts upstream of WNT4 in the signaling pathways that mediate development of kidney tubules and the Muellerian ducts. Plays a role in cranofacial development and is required for normal fusion of the palate during embryonic development (By similarity). . FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. . FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. . FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. . |
Accessions | ENST00000575372.5 I3L0L8 ENST00000393461.2 O14905 ENST00000613753.2 E7EPC3 ENST00000633753.1 Q6ZS96 ENST00000633488.1 ENST00000290015.7 |